Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Short Interest Down 60.0% in February

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) was the recipient of a large decrease in short interest during the month of February. As of February 15th, there was short interest totalling 600 shares, a decrease of 60.0% from the January 31st total of 1,500 shares. Based on an average daily volume of 16,500 shares, the days-to-cover ratio is presently 0.0 days.

Tema Cardiovascular and Metabolics ETF Trading Up 1.1 %

HRTS stock traded up $0.34 during midday trading on Friday, reaching $30.78. The stock had a trading volume of 15,828 shares, compared to its average volume of 14,070. Tema Cardiovascular and Metabolics ETF has a 52-week low of $28.56 and a 52-week high of $36.03. The company has a market cap of $70.79 million, a price-to-earnings ratio of 32.89 and a beta of 0.93. The company’s fifty day simple moving average is $29.82 and its 200 day simple moving average is $32.04.

Tema Cardiovascular and Metabolics ETF Announces Dividend

The firm also recently declared a dividend, which was paid on Thursday, December 12th. Investors of record on Wednesday, December 11th were given a dividend of $0.4693 per share. The ex-dividend date of this dividend was Wednesday, December 11th.

Institutional Trading of Tema Cardiovascular and Metabolics ETF

A hedge fund recently raised its stake in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. grew its stake in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 5.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 167,703 shares of the company’s stock after purchasing an additional 9,008 shares during the period. Tema Cardiovascular and Metabolics ETF makes up about 1.2% of Sterling Investment Advisors Ltd.’s holdings, making the stock its 24th largest holding. Sterling Investment Advisors Ltd. owned approximately 7.29% of Tema Cardiovascular and Metabolics ETF worth $4,842,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Tema Cardiovascular and Metabolics ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.